194 related articles for article (PubMed ID: 24341049)
21. Postoperative N-terminal pro-brain natriuretic peptide level in coronary artery bypass surgery with ventricular dysfunction after perioperative glucose-insulin-potassium treatment.
Foroughi M; Rahimian H; Dabbagh A; Majidi M; Hekmat M; Beheshti M; Shahzamani M
J Cardiothorac Vasc Anesth; 2012 Aug; 26(4):631-6. PubMed ID: 22285123
[TBL] [Abstract][Full Text] [Related]
22. Diastolic dysfunction after coronary artery bypass grafting--the effect of glucose-insulin-potassium infusion.
Tsang MW; Davidoff R; Korach A; Apstein CS; Hesselvik JF; Nguyen H; Shemin RJ; Shapira OM
J Card Surg; 2007; 22(3):185-91. PubMed ID: 17488411
[TBL] [Abstract][Full Text] [Related]
23. High-dose glucose-insulin-potassium after cardiac surgery: a retrospective analysis of clinical safety issues.
Szabó Z; Håkanson E; Maros T; Svedjeholm R
Acta Anaesthesiol Scand; 2003 Apr; 47(4):383-90. PubMed ID: 12694134
[TBL] [Abstract][Full Text] [Related]
24. Management of diabetes during surgery with glucose-insulin-potassium infusion.
Husband DJ; Thai AC; Alberti KG
Diabet Med; 1986 Jan; 3(1):69-74. PubMed ID: 2951140
[TBL] [Abstract][Full Text] [Related]
25. Intravenous glucose-insulin-potassium during off-pump coronary artery bypass surgery does not reduce myocardial injury.
Shim YH; Kweon TD; Lee JH; Nam SB; Kwak YL
Acta Anaesthesiol Scand; 2006 Sep; 50(8):954-61. PubMed ID: 16923090
[TBL] [Abstract][Full Text] [Related]
26. Study protocol of a randomised controlled trial comparing perioperative intravenous insulin, GIK or GLP-1 treatment in diabetes-PILGRIM trial.
Polderman JA; Houweling PL; Hollmann MW; DeVries JH; Preckel B; Hermanides J
BMC Anesthesiol; 2014; 14():91. PubMed ID: 25419179
[TBL] [Abstract][Full Text] [Related]
27. Glucose, insulin and potassium for heart protection during cardiac surgery.
Bruemmer-Smith S; Avidan MS; Harris B; Sudan S; Sherwood R; Desai JB; Sutherland F; Ponte J
Br J Anaesth; 2002 Apr; 88(4):489-95. PubMed ID: 12066723
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of metabolic support with glucose-insulin-potassium for left ventricular pump failure after aortocoronary bypass surgery.
Coleman GM; Gradinac S; Taegtmeyer H; Sweeney M; Frazier OH
Circulation; 1989 Sep; 80(3 Pt 1):I91-6. PubMed ID: 2670331
[TBL] [Abstract][Full Text] [Related]
29. Preconditioning with glucose-insulin-potassium solution and restoration of myocardial function during coronary surgery.
Jovic M; Gradinac S; Lausevic-Vuk L; Nezic D; Stevanovic P; Milojevic P; Djukanovic B
Gen Physiol Biophys; 2009; 28 Spec No():262-70. PubMed ID: 19893109
[TBL] [Abstract][Full Text] [Related]
30. Myocardial protection with Glucose-Insulin-Potassium infusion during adult cardiac surgery.
Ahmad S; Ahmad RA; Qureshi BA; Baig MAR
Pak J Med Sci; 2017; 33(2):325-329. PubMed ID: 28523031
[TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy of glucose-insulin-potassium treatment in coronary artery bypass graft surgery and percutaneous coronary intervention.
Ali-Hassan-Sayegh S; Mirhosseini SJ; Zeriouh M; Dehghan AM; Shahidzadeh A; Karimi-Bondarabadi AA; Sabashnikov A; Popov AF
Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):667-76. PubMed ID: 26265069
[TBL] [Abstract][Full Text] [Related]
32. Effects of glucose-insulin-potassium solution on cardiac cytokines and enzymes.
Celkan MA; Kazaz H; Daglar B; Celik A; Koruk S; Kocoglu H
Thorac Cardiovasc Surg; 2006 Dec; 54(8):532-6. PubMed ID: 17151968
[TBL] [Abstract][Full Text] [Related]
33. The impact of maintaining serum potassium ≥3.6 mEq/L vs ≥4.5 mEq/L on the incidence of new-onset atrial fibrillation in the first 120 hours after isolated elective coronary artery bypass grafting - study protocol for a randomised feasibility trial for the proposed Tight K randomized non-inferiority trial.
Campbell NG; Allen E; Sanders J; Swinson R; Birch S; Sturgess J; Al-Subaie N; Elbourne D; Montgomery H; O'Brien B
Trials; 2017 Dec; 18(1):618. PubMed ID: 29282098
[TBL] [Abstract][Full Text] [Related]
34. Insulin infusion (GIK) in the treatment of type 2 (non-insulin dependent) diabetes during the perioperative period.
Thomas DJ; Platt HS; Alberti KG
Br J Surg; 1986 Nov; 73(11):898-901. PubMed ID: 3790919
[TBL] [Abstract][Full Text] [Related]
35. Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction.
Díaz R; Goyal A; Mehta SR; Afzal R; Xavier D; Pais P; Chrolavicius S; Zhu J; Kazmi K; Liu L; Budaj A; Zubaid M; Avezum A; Ruda M; Yusuf S
JAMA; 2007 Nov; 298(20):2399-405. PubMed ID: 18042917
[TBL] [Abstract][Full Text] [Related]
36. The influence of glucose-insulin-potassium (GIK) on the GH/IGF-1/IGFBP-1 axis during elective coronary artery bypass surgery.
Wallin M; Barr G; öWall A; Lindahl SG; Brismar K
J Cardiothorac Vasc Anesth; 2003 Aug; 17(4):470-7. PubMed ID: 12968235
[TBL] [Abstract][Full Text] [Related]
37. Insulin-dependent diabetes during the peri-operative period. An assessment of continuous glucose-insulin-potassium infusion, and traditional treatment.
Thomas DJ; Platt HS; Alberti KG
Anaesthesia; 1984 Jul; 39(7):629-37. PubMed ID: 6380335
[TBL] [Abstract][Full Text] [Related]
38. Glucose-insulin-potassium therapy in patients with acute coronary syndrome: a meta-analysis of randomized controlled trials.
Jin PY; Zhang HS; Guo XY; Liang WF; Han QF
BMC Cardiovasc Disord; 2014 Nov; 14():169. PubMed ID: 25425404
[TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of intensive intraoperative glycaemic control in cardiopulmonary bypass surgery: a randomised trial.
Rujirojindakul P; Liabsuetrakul T; McNeil E; Chanchayanon T; Wasinwong W; Oofuvong M; Rergkliang C; Chittithavorn V
Acta Anaesthesiol Scand; 2014 May; 58(5):588-96. PubMed ID: 24628042
[TBL] [Abstract][Full Text] [Related]
40. Improved cardiac function with glucose-insulin-potassium after aortocoronary bypass grafting.
Gradinac S; Coleman GM; Taegtmeyer H; Sweeney MS; Frazier OH
Ann Thorac Surg; 1989 Oct; 48(4):484-9. PubMed ID: 2679462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
